| 000 | 01879nam a2200409 a 4500 | ||
|---|---|---|---|
| 001 | EBC3020570 | ||
| 003 | MiAaPQ | ||
| 005 | 20240121041717.0 | ||
| 006 | m o d | | ||
| 007 | cr cn||||||||| | ||
| 008 | 091001s2010 nyua sb 001 0 eng d | ||
| 010 | _z 2009041020 | ||
| 020 | _z9781607419617 (hardcover : alk. paper) | ||
| 020 | _z1607419610 (hardcover : alk. paper) | ||
| 020 | _a9781614704386 (electronic bk.) | ||
| 035 | _a(MiAaPQ)EBC3020570 | ||
| 035 | _a(Au-PeEL)EBL3020570 | ||
| 035 | _a(CaPaEBR)ebr10677961 | ||
| 035 | _a(OCoLC)839305329 | ||
| 040 |
_aMiAaPQ _cMiAaPQ _dMiAaPQ |
||
| 043 | _an-us--- | ||
| 050 | 4 |
_aRM671.5.U6 _bN66 2010 |
|
| 082 | 0 | 4 |
_a615/.1 _222 |
| 245 | 0 | 0 |
_aNonprescription drugs _h[electronic resource] : _bconsidering a new class for behind-the-counter drugs / _cLars P. Eliassen, editor. |
| 260 |
_aNew York : _bNova Science Publishers, _cc2010. |
||
| 300 |
_aviii, 199 p. : _bill. |
||
| 490 | 1 | _aPharmacology-research, safety testing and regulation series | |
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aNonprescription drugs : considerations regarding a behind-the-counter drug class / Government Accountability Office -- Food and Drug Administration behind the counter availability of certain drugs, public meeting / United States Department of Health and Human Services. | |
| 533 | _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
| 650 | 0 |
_aDrugs, Nonprescription _xGovernment policy _zUnited States. |
|
| 655 | 4 | _aElectronic books. | |
| 700 | 1 | _aEliassen, Lars P. | |
| 710 | 2 | _aProQuest (Firm) | |
| 830 | 0 | _aPharmacology-research, safety testing, and regulation series. | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3020570 _zClick to View |
| 999 |
_c154009 _d154009 |
||